K3Gel and Kaymed

MYSLEEPSCAN EXCEEDS PROFIT TARGET THROUGH HIGH CONSUMER SATISFACTION

 

Kaymed’s feedback from UK tests for MySleep are hugely encouraging. Account average sales price on MySleep beds are three times average range prices. The average set selling price is in excess of £2000 and the GM and cash returns of the account both experienced significant rises.

 

The system has performed over 200 body scans during the four month trial with widespread positive feedback from staff and consumers. Enhancements to the booth and instore merchandising package are being rolled out to create more theatre and wow at the point of sale.

 

Kaymed is seeking international licensing partners, interested in adopting the technology within local markets with immediate effect.